Business Description
Kane Biotech Inc
NAICS : 325414
SIC : 3741
ISIN : CA4838092084
Description
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.08 | |||||
Equity-to-Asset | -1.86 | |||||
Debt-to-Equity | -0.88 | |||||
Debt-to-EBITDA | -2.92 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -12.75 | |||||
Beneish M-Score | -5.69 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -56.3 | |||||
3-Year EBITDA Growth Rate | 11 | |||||
3-Year EPS without NRI Growth Rate | -4.3 | |||||
3-Year FCF Growth Rate | 22.8 | |||||
3-Year Book Growth Rate | -78.8 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.73 | |||||
9-Day RSI | 49.74 | |||||
14-Day RSI | 53.97 | |||||
6-1 Month Momentum % | 29.12 | |||||
12-1 Month Momentum % | -18.09 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.34 | |||||
Quick Ratio | 0.32 | |||||
Cash Ratio | 0.07 | |||||
Days Inventory | 6006.12 | |||||
Days Sales Outstanding | 536.48 | |||||
Days Payable | 4576.54 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.7 | |||||
Shareholder Yield % | -13.95 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 73.83 | |||||
Operating Margin % | -2253.69 | |||||
Net Margin % | -3378.52 | |||||
FCF Margin % | -1758.25 | |||||
ROA % | -88.75 | |||||
ROIC % | -35.32 | |||||
ROC (Joel Greenblatt) % | -280.59 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 67.5 | |||||
EV-to-EBIT | -7.86 | |||||
EV-to-EBITDA | -8.29 | |||||
EV-to-Revenue | 176.52 | |||||
EV-to-FCF | -10.71 | |||||
Earnings Yield (Greenblatt) % | -12.72 | |||||
FCF Yield % | -13.79 |